- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Palisade Bio Inc (PALI)
Track today's live Palisade Bio (PALI) share price, performance and key data on this page with our current NASDAQ:PALI stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Palisade Bio share price on the NASDAQ exchange. Use the dropdown to switch exchange for the PALI share price, head to our technical summary section, which provides analysis on Palisade Bio share price buy/sell indicators using real-time data (or discuss the Palisade Bio (PALI) stock price today with other investors in the Palisade Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PALI share price (ISIN: US6963894026) to enhance your trading decisions with our free investment tools and resources.
What Is the Palisade Bio Inc Share Price Today?
The Palisade Bio share price today is 2.100.
What Is the Stock Symbol for Palisade Bio Inc
The stock symbol (or 'ticker') for Palisade Bio Inc is "PALI."
What Stock Exchange Does Palisade Bio Inc Trade On?
Palisade Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Palisade Bio Inc a Good Stock to Buy?
Determining whether Palisade Bio (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PALI share price (ISIN: US6963894026) to enhance your trading decisions with our free investment tools and resources.
What Is the Palisade Bio Inc Share Price Today?
The Palisade Bio share price today is 2.100.
What Is the Stock Symbol for Palisade Bio Inc
The stock symbol (or 'ticker') for Palisade Bio Inc is "PALI."
What Stock Exchange Does Palisade Bio Inc Trade On?
Palisade Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Palisade Bio Inc a Good Stock to Buy?
Determining whether Palisade Bio (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.080
2.135
52 wk Range
0.530
2.855
PALI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.0802.135
52 wk Range
0.5302.855
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PALI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
10.222
Upside
+386.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.222
(+386.77% Upside)
Earnings
Latest Release
10/08/2026
EPS / Forecast
-0.05 / -0.05
Revenue / Forecast
500K / --
Compare PALI to Peers and Sector
Metrics to compare | PALI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPALIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.5x | −1.7x | −0.4x | |
PEG Ratio | −0.12 | −0.05 | 0.00 | |
Price/Book | 3.0x | 3.4x | 2.6x | |
Price / LTM Sales | 731.9x | 13.9x | 3.1x | |
Upside (Analyst Target) | 281.0% | 83.9% | 48.6% | |
Fair Value Upside | Unlock | 8.4% | 5.8% | Unlock |
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical product candidate includes PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn’s disease. The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Palisade Bio (NASDAQ: PALI) Share Price Today?
The Palisade Bio stock price today is 2.100 USD.
What Stock Exchange Does Palisade Bio (PALI) Trade On?
Palisade Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Palisade Bio?
The stock symbol (also called a 'ticker') for Palisade Bio is "PALI."
What Is the Current Palisade Bio Market Capitalisation?
As of today, Palisade Bio (NASDAQ: PALI) market cap is 365.970M USD.
What Is Palisade Bio's (PALI) Earnings Per Share (TTM)?
The Palisade Bio EPS is currently -0.202 (Trailing Twelve Months).
When Is the Next Palisade Bio Earnings Date?
Palisade Bio's next earnings report will be released on 16/11/2026.
Is PALI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Palisade Bio moving averages and other technical indicators, the daily buy/sell signal for PALI stock is Strong Buy.
How Many Times Has Palisade Bio Stock Split?
Palisade Bio has split 5 times. (See the PALI stock split history page for full effective split date and price information.)
What is the current trading status of Palisade Bio (NASDAQ: PALI)?
As of 24/08/2026, Palisade Bio (PALI) is trading at a share price of 2.100 USD, with a previous close of 2.100 USD. The stock has fluctuated within a day range of 2.080 USD to 2.135 USD, while its 52-week range spans from 0.530 USD to 2.855 USD.
What Is Palisade Bio (PALI) Price Target According to Analysts?
The average 12-month price target for Palisade Bio is 10.222 USD, with a high estimate of 25 USD and a low estimate of 5 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +386.77% Upside potential.
What Is the PALI Premarket Price?
PALI's last pre-market stock price is 2.072 USD. The pre-market share volume is 41,620.000, and the stock has decreased by 0.012, or 0.580%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.